ATMS

Artemis Therapeutics Inc. [ATMS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ATMS Stock Summary

In the News

ATMS Financial details

Company Rating
Sell
Market Cap
55.79M
Income
-737K
Revenue
671K
Book val./share
-0
Cash/share
0
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
21 Aug 2023
P/E
-40.51
Forward P/E
-
PEG
-0.33
P/S
119.14
P/B
-47.93
P/C
-
P/FCF
-108.76
Quick Ratio
0.12
Current Ratio
0.15
Debt / Equity
-0.23
LT Debt / Equity
-0.23
-
-
EPS (TTM)
-0.09
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
3.73%
Revenue Q/Q
-14.56%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-473%
ROE
177%
ROC
1.61%
Gross Margin
83%
Oper. Margin
-304%
Profit Margin
-294%
Payout
-
Shs Outstand
112.03M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
0.1121-4.5
52W High
-
52W Low
-
RSI
-
Rel Volume
0.71
Avg Volume
1.53K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0.7%, 0.7%
Prev Close
-
Price
-
Change
-

ATMS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.050000
Net income per share
-0.1-0.02-0.02-0.010
Operating cash flow per share
-0.1-0.02000
Free cash flow per share
-0.1-0.02000
Cash per share
00000
Book value per share
-0.06-0.05-0.07-0.020
Tangible book value per share
-0.06-0.05-0.07-0.020
Share holders equity per share
-0.06-0.05-0.07-0.020
Interest debt per share
00.020.020.010
Market cap
3.09M266.69K2.05M24.83M66.19B
Enterprise value
3.09M367.69K2.16M25.03M66.19B
P/E ratio
-6.03-2.2-16.95-137.96-48.99K
Price to sales ratio
11.94000212.82K
POCF ratio
-5.97-2.47-2.05K-340.17-169.71K
PFCF ratio
-5.97-2.47-2.05K-340.17-159.1K
P/B Ratio
-10.41-1.12-5.94-50.07-64.51K
PTB ratio
-10.41-1.12-5.94-50.07-64.51K
EV to sales
11.91000212.82K
Enterprise value over EBITDA
-6.01-2.19-12.93-162.52-49.28K
EV to operating cash flow
-5.96-3.4-2.16K-342.84-169.71K
EV to free cash flow
-5.96-3.4-2.16K-342.84-159.11K
Earnings yield
-0.17-0.45-0.06-0.010
Free cash flow yield
-0.17-0.4000
Debt to equity
0-0.43-0.32-0.4-0.35
Debt to assets
04.6810281.34
Net debt to EBITDA
0.01-0.6-0.65-1.27-0.22
Current ratio
0.080.140.030.010.14
Interest coverage
0-28-23.86-11.85339.75
Income quality
1.010.890.010.440.29
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
2.030003.06
Research and developement to revenue
0.950000
Intangibles to total assets
00000.13
Capex to operating cash flow
00000.07
Capex to revenue
0000-0.08
Capex to depreciation
0000-1.63
Stock based compensation to revenue
0.440000.79
Graham number
0.360.160.190.050
ROIC
2.60.870.490.552.13
Return on tangible assets
-19-5.5-11-25.71-5.87
Graham Net
-0.06-0.05-0.07-0.020
Working capital
-297K-135K-345K-496K-861K
Tangible asset value
-297K-238K-345K-496K-1.06M
Net current asset value
-297K-238K-345K-496K-1.15M
Invested capital
0-0.43-0.32-0.4-0.35
Average receivables
39K20K15K8K23.5K
Average payables
107K80.5K00285.5K
Average inventory
000023.5K
Days sales outstanding
28.1900048.12
Days payables outstanding
00003.86K
Days of inventory on hand
0000317.69
Receivables turnover
12.950007.59
Payables turnover
00000.09
Inventory turnover
00001.15
ROE
1.730.510.350.361.32
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00.02000
Net income per share
-0.01-0.09000
Operating cash flow per share
0-0.01000
Free cash flow per share
0-0.01000
Cash per share
00.01000
Book value per share
-0.01-0.18-0.0100
Tangible book value per share
-0.01-0.19-0.0100
Share holders equity per share
-0.01-0.18-0.0100
Interest debt per share
0.010.06000
Market cap
156.9M6.62M67M55.79B55.79B
Enterprise value
157.17M6.92M67.38M55.79B55.79B
P/E ratio
-88.54-3.19-71.58929.88K0
Price to sales ratio
1.33K57.06387.26270.84K317.01K
POCF ratio
-2.82K-161.43-697.8800
PFCF ratio
-2.45K-112.88-697.8800
P/B Ratio
-241.38-6.45-57.560-40.11K
PTB ratio
-241.38-6.45-57.560-40.11K
EV to sales
1.33K59.65389.5270.84K317.01K
Enterprise value over EBITDA
-356.95-14.12-259.17-204.37K-364.66K
EV to operating cash flow
-2.82K-168.77-701.9200
EV to free cash flow
-2.45K-118.01-701.9200
Earnings yield
0-0.08000
Free cash flow yield
0-0.01000
Debt to equity
-0.55-0.35-0.430-0.23
Debt to assets
11.341.7104.42
Net debt to EBITDA
-0.62-0.61-1.490-2.07
Current ratio
0.310.140.1500.1
Interest coverage
-445-41.1717.600
Income quality
0.130.080.3900
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
2.463.291.231.181.16
Research and developement to revenue
00000
Intangibles to total assets
0.10.130.1200.44
Capex to operating cash flow
0.150.43000
Capex to revenue
-0.07-0.15000
Capex to depreciation
-1.78-4.41000
Stock based compensation to revenue
0.491.070.600
Graham number
0.050.610.0200
ROIC
1.730.80.3900
Return on tangible assets
-1.38-2.25-0.9100
Graham Net
-0.02-0.21-0.0100
Working capital
-494K-861K-999K0-1.11M
Tangible asset value
-686K-1.06M-1.2M0-1.55M
Net current asset value
-782K-1.15M-1.28M0-1.46M
Invested capital
-0.55-0.35-0.430-0.23
Average receivables
65.54K57K38K17.5K4K
Average payables
216.78K464.5K604K318.5K332K
Average inventory
66.06K56.5K41K17.5K52K
Days sales outstanding
55.6831.8118.2104.09
Days payables outstanding
8.06K1.77K1.98K06.64K
Days of inventory on hand
1.49K145.86108.6201.04K
Receivables turnover
1.622.834.94022
Payables turnover
0.010.050.0500.01
Inventory turnover
0.060.620.8300.09
ROE
0.680.50.200
Capex per share
00000

ATMS Frequently Asked Questions

What is Artemis Therapeutics Inc. stock symbol ?

Artemis Therapeutics Inc. is a US stock , located in New york of Ny and trading under the symbol ATMS

What is Artemis Therapeutics Inc. stock quote today ?

Artemis Therapeutics Inc. stock price is $- today.

Is Artemis Therapeutics Inc. stock public?

Yes, Artemis Therapeutics Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap